Arcadia vs Innovaccer (2026)

AI Health Index verifiedSeptember 22, 2026
Verdict

The AI Health Index reads this as a choice about how much of the work a health system wants its vendor to perform, because both platforms are the data foundation an organization buys to run risk contracts. Arcadia has stayed a data and analytics company: integration across more than fifty electronic health record systems resolved through its own master patient index, Medicare claims benchmarks with the provenance named, validation from the National Committee for Quality Assurance that data flowing through the platform is fit to be scored on, and a generative assistant built on OpenAI models now layered on top. Innovaccer is becoming an operator: five acquisitions have added live health coaches, revenue cycle services and payer utilization management, and the Centers for Medicare and Medicaid Services has accepted it as a participant in a federal care model rather than only a supplier to participants. Choose Arcadia where the requirement is a validated data foundation, a price the buyer can size before a sales call, and intelligence the buyer brings or builds on top. Choose Innovaccer where breadth and current independent validation decide, provided the buyer establishes which capabilities are production proven in its own setting. Neither publishes any bias testing. One thing a buyer should know: the documented failure mode in claims based risk scoring is silent, a patient scored too low is simply never contacted and no incident ever surfaces, so the one question to ask both vendors is what the risk models predict and whether subgroup performance has been measured.

The case for Arcadia
  • Arcadia's clinical data holds the Certified Data Partner designation in the National Committee for Quality Assurance Data Aggregator Validation program and a separate Validated Data Stream designation covering HEDIS measurement, meaning an external body examined whether the data itself is fit to be scored on. The AI Health Index records no equivalent third party validation of the data artifact on Innovaccer's record.
  • Arcadia prices in public. Its AWS Marketplace listing prices the data platform at $1,275,120 per 100,000 members over a 36 month contract, about 35 cents per member per month, with analytics, care management and health plan packages priced on the same basis and the point of care record overlay at $900 per user. A buyer can size the software cost before a sales conversation. Innovaccer publishes no price.
  • Arcadia names its certifications as its own: its home page shows ISO 27001, a SOC 2 Type One report and HITRUST i1, and its marketplace listing describes the platform as HITRUST CSF certified. The currency questions are real, since the ISO badge names the 2013 edition and the HITRUST i1 carries no date. Innovaccer's published security wording reads as ambiguous between holding its own certifications and operating inside a customer's certified environment.
  • Arcadia remains a supplier rather than a program participant, so a buyer's performance data does not sit with a vendor whose own results are at stake in the same federal models its customers compete in. The AI Health Index regards that separation as a point Innovaccer can no longer claim.
The case for Innovaccer
  • In the 2026 Best in KLAS awards Innovaccer took the top score in three categories at once, Gravity at 93.2 for provider analytics against a market average of 83.9, Galaxy at 90.5 for payer analytics and Cured at 90.1 for customer relationship management, drawn from validated customer interviews rather than vendor submissions. The AI Health Index records no current independent performance validation of that breadth for Arcadia.
  • Innovaccer states single tenant deployment inside the customer's own cloud with the position that no protected health information leaves the customer's control. Arcadia's published material names AWS as its cloud but leaves tenancy, residency and continuity unanswered.
  • Through the Story Health and CaduceusHealth acquisitions Innovaccer now fields live health coaches working with remote biometric monitoring and a United States based revenue cycle services team serving nearly 4,000 providers, so a buyer can purchase operated services alongside software. The AI Health Index records Arcadia as selling the platform while the buyer runs the work.

This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Arcadia and Innovaccer are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded

At a Glance

Plain facts

Fact Arcadia Innovaccer
Primary category Value Based Care Intelligence Health System AI Platforms
Founded Not recorded 2014
Headquarters Boston, Massachusetts, United States San Francisco, California
Website arcadia.io innovaccer.com
Attribute Matrix

Side by Side

Select any grade to read the note behind it.

Axis
A
Arcadia
I
Innovaccer
AI Centrality
Autonomy and Oversight Model
Model and Technology Transparency
Model Supply Chain Disclosure
Clinical and Operational Evidence
AI Safety and PHI Stewardship
HIPAA and BAA Posture
Security Certifications and Trust Center
FDA and Regulatory Status
AI Governance and Bias Disclosure
AI Liability and Recourse
EHR and Interoperability Depth
Deployment Model and Data Residency
Commercial Transparency
Setting and Specialty Coverage
Citable Summaries

Each vendor in one paragraph

Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.

Arcadia

Arcadia sells the data foundation underneath value based care, and increasingly the models that run on top of it. The platform ingests clinical records from more than fifty record systems, payer claims, admission and discharge feeds, pharmacy data and social determinants information, resolves them to a single member through a proprietary master patient index, applies natural language processing to unstructured text, and presents the result to population health, risk, quality and network teams.

Source: AI Health Index, September 2026

Innovaccer

Innovaccer, founded in 2014 and headquartered in San Francisco, sells what it calls an agentic cloud for healthcare: the Gravity platform, which unifies record system, claims, pharmacy, laboratory, monitoring and social determinants data (a reported 80 million patient records) and runs applications and AI agents on top.

Source: AI Health Index, September 2026

FAQ

Questions buyers ask

How are Arcadia and Innovaccer priced and sold?

For Arcadia, the listing states usage based charges apply on top of the contract price and that AWS infrastructure costs may be added.

Innovaccer sells the Gravity platform and named solutions (Flow, Atlas, Galaxy, Cured, Comet, PQS, Story Health, Humbi) to providers, payers, the public sector and life sciences, with deployment offered self serve, led by a systems integrator or vendor managed, and delivery partners including Mastek and Coforge. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 22, 2026. No vendor pays for placement.

How do Arcadia and Innovaccer handle patient data?

Arcadia's own pages say its generative assistant is powered by OpenAI large language models reading longitudinal patient records, so clinical content reaches an outside model provider by design. Nothing on the home, integration, privacy or marketplace pages states what OpenAI retains, whether prompts and outputs are logged and for how long, whether customer data trains or tunes any model, or whether learning crosses customer boundaries.

For Innovaccer, the trust center states that the company does not train its models on customer data, describes privacy by design and data minimization, AES-256 encryption at rest, TLS 1.3 in transit and role based access, and its governance framework commits to documenting the data sources used in training and operating each AI application. Earlier material describes single tenant deployment in the customer's own cloud. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 22, 2026. No vendor pays for placement.

Which settings and specialties do Arcadia and Innovaccer cover?

With Arcadia, data breadth supports the coverage claim rather than decorating it.

In Innovaccer's case, three of the lines carry top KLAS scores and several value based care deployments carry figures, but the suite grew through five acquisitions, and nothing shows which capabilities are production proven in which setting; the newest products are the least evidenced. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 22, 2026. No vendor pays for placement.

What evidence is published for Arcadia and Innovaccer?

For Arcadia, the case study library names Southwestern Health Resources, Ascension Illinois (AMITA Health ACO and CIN), Belong Health and others, told as narratives rather than measured results.

With Innovaccer, the acquired specialty care business reports a 6.9 percent thirty day heart failure readmission rate against 18.1 percent nationally. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 22, 2026. No vendor pays for placement.

Keep Comparing

Related comparisons

Other published head to head assessments involving these vendors or their closest peers.

Disclosure

Innovaccer publishes no price of any kind. Arcadia prices its platform and packages on its AWS Marketplace listing, but neither vendor prices implementation, the cost third party buyer guidance flags as the principal risk in this category. Arcadia names OpenAI as the model supplier behind its generative assistant; Innovaccer names no base model. Neither publishes per model accuracy or any bias testing, in a product category where a widely cited study documented claims based risk stratification underestimating illness in Black patients.

Arcadia's headline outcome figures, 81 percent in visit diagnosis capture, 59 percent more closed risk per patient and a 24 percent reduction in inpatient admissions, carry no denominator, time period or method. The security report its home page shows is a SOC 2 Type One rather than a Type Two. Innovaccer's own material leaves a training tension unreconciled, a platform described as continuously trained on real world healthcare data alongside a statement that no protected health information leaves the customer's control, and nothing published describes how its participation in a federal care model is separated from serving customers who compete in it.

Demand implementation cost from both. From Arcadia, ask whether the marketplace prices match a direct contract, for a current SOC 2 Type Two, and for the arithmetic behind the outcome claims. From Innovaccer, ask for the unit of charge, the training data reconciliation and the conflict separation.